Heather Potters and the company she co-founded, Pharmajet, is changing that. How? by developing auto-disabled syringes in place of standard syringes. Once used, the PharmaJet syringe is also auto-disabled and cannot be re-used.
Not only is Pharmajet paving the way for safe, effective delivery of inoculations and reducing the spread of infectious diseases; they are giving piece of mind to "Belenophobic" (people who fear needles). 2 persons in 10 is apprehensive of needles which can influence their decision to receive needed medications traditionally delivered by syringes, including flue vaccinations.
Please join us on June 7th for a special luncheon presentation at The Yale Club in New York City where Heather will share her story of how her passion for technology has influenced the direction at Pharmajet and that, int turn, is making a profound contribution to vaccination program around the world.
Click here to learn more about the event and the other presenters. This event is hosted by The Global Leaders and sponsored by M.M. Dillon & Company.
About Heather Potters
Heather has a 20 year career in private equity investing, which began with a focus in the countries of Central and Eastern Europe and CIS--starting in Poland—since 1991. She has managed three private equity funds, starting with the Polish American Enterprise Fund, later turning into Enterprise Investors; thereafter co-founding the first focused regional investment fund for the CEE/CIS region, called Baring Communications Equity. For the past decade, she has also been an active angel investor, leading private placement rounds of equity with other high net worth investors. In particular, she spends most of her time focused on PharmaJet, a needle-free medical device company, which she co-founded in 2005 and where she is Chairman and active in the company’s global business development and expansion. PharmaJet’s accomplishments, together with her passion about the technology and its ability to make a profound contribution to vaccination programs around the world, have been recognized by the Tech Awards, naming her as a Tech Laureate for 2010 for contributions to global humanity in health care, and recently as a regional finalist for the Ernst and Young Entrepreneur of the Year. Investments managed or led by Ms. Potters have touched more than 15 jurisdictions around the world, including active board positions within public and privately held companies, in a variety of industries including manufacturing, IT, service, media, communications, internet, real estate, and medical device activities. Heather holds an MBA from The Wharton School, and a BA in International Management from Claremont McKenna College.